Acute exercise enhancement of pneumococcal vaccination response: A randomised controlled trial of weaker and stronger immune response

Vaccine

Volumn 30, Issue 45, 2012, Pages 6389-6395

  Edwards, Kate M ^a,b   Pung, Meredith A ^a   Tomfohr, Lianne M ^a   Ziegler, Michael G ^c   Campbell, John P ^d   Drayson, Mark T ^d   Mills, Paul J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Acute exercise; Antibody; Behavioural adjuvant; Pneumococcal vaccination

Indexed keywords

CYTOKINE; PNEUMOCOCCUS VACCINE;

ADULT; ANTIBODY PRODUCTION; ARM CIRCUMFERENCE; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; EXERCISE; FEMALE; HEART RATE; HIGH RISK POPULATION; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; MALE; NORMAL HUMAN; OUTCOME ASSESSMENT; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TASK PERFORMANCE; VACCINATION;

ADULT; ANTIBODIES, BACTERIAL; ANTIBODY FORMATION; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; EXERCISE; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-6; MALE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; YOUNG ADULT;

EID: 84866517405     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.08.022     Document Type: Article

References (46)

1. Bliss S.J., O'Brien K.L., Janoff E.N., Cotton M.F., Musoke P., Coovadia H., et al. The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease. Lancet Infect Dis 2008, 8(January (1)):67-80.
2. Grubeck-Loebenstein B., Della Bella S., Iorio A.M., Michel J.P., Pawelec G., Solana R. Immunosenescence and vaccine failure in the elderly. Aging Clin Exp Res 2009, 21(June (3)):201-209.
3. Rahier J.F., Moutschen M., Van Gompel A., Van Ranst M., Louis E., Segaert S., et al. Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatology (Oxford) 2010, 49(October (10)):1815-1827.
4. Liu J., Kjeken R., Mathiesen I., Barouch D.H. Recruitment of antigen-presenting cells to the site of inoculation and augmentation of human immunodeficiency virus type 1 DNA vaccine immunogenicity by in vivo electroporation. J Virol 2008, 82(June (11)):5643-5649.
5. Chen X., Kim P., Farinelli B., Doukas A., Yun S.H., Gelfand J.A., et al. A novel laser vaccine adjuvant increases the motility of antigen presenting cells. PLoS ONE 2010, 5(10):e13776.
6. Edwards K.M., Burns V.E., Carroll D., Drayson M., Ring C. The acute stress-induced immunoenhancement hypothesis. Exerc Sport Sci Rev 2007, 35(July (3)):150-155.
7. Edwards K.M., Burns V.E., Adkins A.E., Carroll D., Drayson M., Meningococcal Ring C. A vaccination response is enhanced by acute stress in men. Psychosom Med 2008, 70(February (2)):147-151.
8. Edwards K.M., Burns V.E., Allen L.M., McPhee J.S., Bosch J.A., Carroll D., et al. Eccentric exercise as an adjuvant to influenza vaccination in humans. Brain Behav Immun 2007, 21(2):209-217.
9. Edwards K.M., Burns V.E., Reynolds T., Carroll D., Drayson M., Ring C. Acute stress exposure prior to influenza vaccination enhances antibody response in women. Brain Behav Immun 2006, 20(2):159-168.
10. Edwards K.M., Campbell J.P. Acute exercise as an adjuvant to influenza vaccination. Am J Lifestyle Med 2011, 5(6):512-517.
11. Tovey M.G., Lallemand C. Adjuvant activity of cytokines. Methods Mol Biol 2010, 626:287-309.
12. Dhabhar F.S. Stress-induced augmentation of immune function - the role of stress hormones, leukocyte trafficking, and cytokines. Brain Behav Immun 2002, 16(6):785-798.
13. Chou H.Y., Lin X.Z., Pan W.Y., Wu P.Y., Chang C.M., Lin T.Y., et al. Hydrogel-delivered GM-CSF overcomes nonresponsiveness to hepatitis B vaccine through the recruitment and activation of dendritic cells. J Immunol 2010, 185(November (9)):5468-5475.
14. Warren T.L., Weiner G.J. Uses of granulocyte-macrophage colony-stimulating factor in vaccine development. Curr Opin Hematol 2000, 7(May (3)):168-173.
15. Krakauer T. Levels of interleukin 6 and tumor necrosis factor in serum from humans vaccinated with live, attenuated Francisella tularensis. Clin Diagn Lab Immunol 1995, 2(4):487-488.
16. Proske U., Morgan D.L. Muscle damage from eccentric exercise: mechanism, mechanical signs, adaptation and clinical applications. J Physiol 2001, 537(Pt 2):333-345.
17. Dear K., Holden J., Andrews R., Tatham D. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2003, 4:CD000422.
18. Cornu C., Yzebe D., Leophonte P., Gaillat J., Boissel J.P., Cucherat M. Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-analysis of randomized trials. Vaccine 2001, 19(September (32)):4780-4790.
19. Vila-Corcoles A., Ochoa-Gondar O., Guzman J.A., Rodriguez-Blanco T., Salsench E., Fuentes C.M. Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older. BMC Infect Dis 2010, 10:73.
20. Gaillat J. Should patients with chronic obstructive pulmonary disease be vaccinated against pneumococcal diseases?. Expert Rev Respir Med 2009, 3(December (6)):585-596.
21. Cohen S., Miller G.E., Rabin B.S. Psychological stress and antibody response to immunization: a critical review of the human literature. Psychosom Med 2001, 63(1):7-18.
22. Borg G. The perception of physical performance. Frontiers of fitness 1971, Charles C. Thomas, Springfield, IL. R.J. Shephard (Ed.).
23. Melzack R. The short-form McGill pain questionnaire. Pain 1987, 30(2):191-197.
24. Denham B.C., Clarke S.C. Serotype incidence and antibiotic susceptibility of Streptococcus pneumoniae causing invasive disease in Scotland, 1999-2002. J Med Microbiol 2005, 54(April (Pt 4)):327-331.
25. Sleeman K., Knox K., George R., Miller E., Waight P., Griffiths D., et al. Invasive pneumococcal disease in England and Wales: vaccination implications. J Infect Dis 2001, 183(January (2)):239-246.
26. Whitelegg A.M., Birtwistle J., Richter A., Campbell J.P., Turner J.E., Ahmed T.M., et al. Measurement of antibodies to pneumococcal, meningococcal and haemophilus polysaccharides, and tetanus and diphtheria toxoids using a 19-plexed assay. J Immunol Methods 2012, (March (377)):37-46.
27. Lal G., Balmer P., Joseph H., Dawson M., Borrow R. Development and evaluation of a tetraplex flow cytometric assay for quantitation of serum antibodies to Neisseria meningitidis serogroups A, C, Y, and W-135. Clin Diagn Lab Immunol 2004, 11(2):272-279.
28. WHO. Training manual for enzyme linked immunosorbent assay for the quantitation of streptococcus pneumoniae serotype-specific IgG (PN PS ELISA). Available at, 2004: accessed 03.03.10. http://wwwvaccineuabedu/.
29. Tabachnick B.G., Fidell L.S. Using multivariate statistics 2007, Allyn and Bacon, New York. 5th edition.
30. Torling J., Hedlund J., Konradsen H.B., Ortqvist A. Revaccination with the 23-valent pneumococcal polysaccharide vaccine in middle-aged and elderly persons previously treated for pneumonia. Vaccine 2003, 22(December (1)):96-103.
31. Campbell J.P., Edwards K.M., Ring C., Drayson M.T., Bosch J.A., Inskip A., et al. The effects of vaccine timing on the efficacy of an acute eccentric exercise intervention on the immune response to an influenza vaccine in young adults. Brain Behav Immun 2010, (February (24)):236-242.
32. Edwards K.M., Campbell J.P., Ring C., Drayson M.T., Bosch J.A., Downes C., et al. Exercise intensity does not influence the efficacy of eccentric exercise as a behavioural adjuvant to vaccination. Brain Behav Immun 2010, 24(May (4)):623-630.
33. Treanor J., Keitel W., Belshe R., Campbell J., Schiff G., Zangwill K., et al. Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults. Vaccine 2002, 20(January (7-8)):1099-1105.
34. Vajo Z., Tamas F., Jankovics I. A reduced-dose seasonal trivalent influenza vaccine is safe and immunogenic in adult and elderly patients in a randomized controlled trial. Clin Vaccine Immunol 2012, 19(March (3)):313-318.
35. Engler R.J., Nelson M.R., Klote M.M., VanRaden M.J., Huang C.Y., Cox N.J., et al. Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses. Arch Intern Med 2008, 168(December (22)):2405-2414.
36. Turchi M.D., Martelli C.M., Ferraz M.L., Silva A.E., Cardoso DdD, Martelli P., et al. Immunogenicity of low-dose intramuscular and intradermal vaccination with recombinant hepatitis B vaccine. Rev Inst Med Trop Sao Paulo 1997, 39(January-February (1)):15-19.
37. Vedhara K., Cox N.K., Wilcock G.K., Perks P., Hunt M., Anderson S., et al. Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination. Lancet 1999, 353(9153):627-631. [see comments].
38. Burns V.E., Carroll D., Drayson M., Whitham M., Ring C. Life events, perceived stress and antibody response to influenza vaccination in young, healthy adults. J Psychosom Res 2003, 55(6):569-572.
39. Viswanathan K., Dhabhar F.S. Stress-induced enhancement of leukocyte trafficking into sites of surgery or immune activation. Proc Natl Acad Sci USA 2005, 102(16):5808-5813.
40. Havas E., Lehtonen M., Vuorela J., Parviainen T., Vihko V. Albumin clearance from human skeletal muscle during prolonged steady-state running. Exp Physiol 2000, 85(November (6)):863-868.
41. Havas E., Parviainen T., Vuorela J., Toivanen J., Nikula T., Vihko V. Lymph flow dynamics in exercising human skeletal muscle as detected by scintography. J Physiol 1997, 504(October (Pt 1)):233-239.
42. Nosaka K., Newton M., Sacco P. Muscle damage and soreness after endurance exercise of the elbow flexors. Med Sci Sports Exerc 2002, 34(6):920-927.
43. WHO U, World Bank State of the world's vaccines and immunization. Geneva; 2009.
44. Cohen S., Kamarck T., Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983, 24(4):385-396.
45. Buysse D.J., Reynolds C.F., Monk T.H., Berman S.R., Kupfer D.J. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 1989, 28(May (2)):193-213.
46. Godin G., Jobin J., Bouillon J. Assessment of leisure time exercise behavior by self-report: a concurrent validity study. Can J Public Health 1986, 77(September-October (5)):359-362.